Scholarlink

Background <p>Osteosarcoma (OS) is a primary bone malignancy; however, its exact mechanism of development remains largely unknown. Recent studies have shown that miR-381-3p can affect the development of various cancers. However, its biological effects and mechanisms of OS progression have not yet been elucidated. This study aimed to examine the biological role of miR-381-3p in OS.</p> Methods <p>We screened differentially expressed microRNAs in OS using bioinformatics tools. miR-381-3p expression was assessed by quantitative real-time-polymerase chain reaction, and the effect of miR-381-3p on OS growth was evaluated in vitro and in vivo by functional assays. The direct interaction between <i>PFKFB3</i> and miR-381-3p was validated by dual luciferase reporter assay. Finally, metabolic alterations in OS cells were monitored using an XF96 Metabolic Flux Analyzer.</p> Results <p>miR-381-3p expression was significantly downregulated in OS samples and cells. miR-381-3p also participated in suppressing OS cell growth and was associated with the Warburg effect. The <i>PFKFB3</i> gene, encoding an essential glycolytic enzyme, was identified as a downstream gene of miR-381-3p, and <i>PFKFB3</i> overexpression partly rescued the inhibitory impact of miR-381-3p on OS growth.</p> Conclusion <p>miR-381-3p directly targets and negatively regulates <i>PFKFB3</i> expression, thereby inhibiting OS proliferation by controlling the Warburg effect. The miR-381-3p/<i>PFKFB3</i> axis may be a promising therapeutic target for OS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

MiR-381-3p inhibits Warburg effect and progression in osteosarcoma via targeting PFKFB3

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月27日

查看全文
  • Huiqun Jiang,
  • Jingbin Wu,
  • Chao Wang,
  • Jiahao Xia,
  • Yuan Tao,
  • Zhongxing Wan,
  • Dong Li,
  • Weihao Duan,
  • Yiping Weng,
  • Yu Zhang

摘要

Background

Osteosarcoma (OS) is a primary bone malignancy; however, its exact mechanism of development remains largely unknown. Recent studies have shown that miR-381-3p can affect the development of various cancers. However, its biological effects and mechanisms of OS progression have not yet been elucidated. This study aimed to examine the biological role of miR-381-3p in OS.

Methods

We screened differentially expressed microRNAs in OS using bioinformatics tools. miR-381-3p expression was assessed by quantitative real-time-polymerase chain reaction, and the effect of miR-381-3p on OS growth was evaluated in vitro and in vivo by functional assays. The direct interaction between PFKFB3 and miR-381-3p was validated by dual luciferase reporter assay. Finally, metabolic alterations in OS cells were monitored using an XF96 Metabolic Flux Analyzer.

Results

miR-381-3p expression was significantly downregulated in OS samples and cells. miR-381-3p also participated in suppressing OS cell growth and was associated with the Warburg effect. The PFKFB3 gene, encoding an essential glycolytic enzyme, was identified as a downstream gene of miR-381-3p, and PFKFB3 overexpression partly rescued the inhibitory impact of miR-381-3p on OS growth.

Conclusion

miR-381-3p directly targets and negatively regulates PFKFB3 expression, thereby inhibiting OS proliferation by controlling the Warburg effect. The miR-381-3p/PFKFB3 axis may be a promising therapeutic target for OS.